J. Burgess

发表

Novel ATP-competitive kinesin spindle protein inhibitors.

Nicholas D. Adams, K. Wood, J. Finer, 2007, Journal of medicinal chemistry.

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295.

J. D. Elliott, Nicholas D. Adams, X. Qian, 2010, ACS medicinal chemistry letters.

Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors.

J. Luengo, A. P. Graves, M. Pappalardi, 2019, ACS medicinal chemistry letters.

Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase.

Nicholas D. Adams, Ramona N Plant, J. Adams, 2010, Journal of medicinal chemistry.

Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists.

C. E. Peishoff, K. Erhard, R. Calvo, 1996, Journal of medicinal chemistry.

Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

Ruth Lehr, B. Olson, N. Laping, 2002, Journal of medicinal chemistry.

The use of γ-turn mimetics to define peptide secondary structure

J. Callahan, D. Eggleston, W. Huffman, 1993 .

Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide

John W. Bean, James F. Callahan, R. Calvo, 1993 .

Design and synthesis of a C7 mimetic for the predicted gamma-turn conformation found in several constrained RGD antagonists.

C. E. Peishoff, K. Kopple, J. Callahan, 1992, Journal of medicinal chemistry.

Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.

A. P. Graves, L. Lafrance, Christine Thompson, 2012, ACS medicinal chemistry letters.

Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.

Kaushik Raha, Dashyant Dhanak, David Sutton, 2010, ACS medicinal chemistry letters.

Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT)

J. Cuozzo, M. Clark, Paolo A. Centrella, 2015, ACS medicinal chemistry letters.

Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant

K. Ellingson, J. Nikolich-Žugich, M. Jergović, 2022, medRxiv.

Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT)

Nicholas D. Adams, J. Cuozzo, M. Clark, 2015, ACS medicinal chemistry letters.